← Back to Search

PFC I-PASS Intervention for Enhanced Healthcare Communication

N/A

Waitlist Available

Led By Alisa Khan, MD, MPH

Research Sponsored by Boston Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months (including usual care and intervention implementation data collection which will happen sequentially)per site (8 sites total)

Awards & highlights

Study Summary

This trial will test an improved version of PFC I-PASS, which changed how doctors & nurses talk to patients & families, to include interpreters and training for communication & cultural humility. It aims to improve patient experience & reduce adverse events.

Who is the study for?

This trial is for hospital leaders, patients aged 13+, nurses, parents/caregivers who speak one of the study languages, and medical staff at participating pediatric units. It aims to improve communication during rounds with families, especially those facing language barriers.Check my eligibility

What is being tested?

The study compares PFC I-PASS+ (which includes interpreters and cultural training) with the original PFC I-PASS and usual care in hospitals. The goal is to see if these interventions can enhance how doctors and nurses communicate with patients' families.See study design

What are the potential side effects?

Since this trial focuses on communication strategies rather than medications or medical procedures, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months (including usual care and intervention implementation data collection which will happen sequentially)per site (8 sites total)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months (including usual care and intervention implementation data collection which will happen sequentially)per site (8 sites total)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months (including usual care and intervention implementation data collection which will happen sequentially)per site (8 sites total) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adverse Event Rates

Secondary outcome measures

Observations of Quality and Frequency of Communications

Patient/Family Experience of Discrimination (Discrimination In Medical Settings Scale)

Patient/Family Experience with Care Questionnaire

+1 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: PFC I-PASS+ InterventionExperimental Treatment1 Intervention

PFC I-PASS+ includes all parts of PFC I-PASS plus having interpreters on and after rounds and training doctors about communication and cultural humility.

Group II: PFC I-PASS InterventionExperimental Treatment1 Intervention

Patient and Family-Centered I-PASS is a bundle of communication interventions to improve the quality of information exchange between physicians, nurses, and families, and to better integrate families into all aspects of daily decision making in hospitals. The intervention included a health literacy-informed, structured communication framework for family-centered rounds; written rounds summaries for families; a training and learning program; and strategies to support teamwork and implementation.

Group III: Usual careActive Control1 Intervention

Unstructured communication during rounds and unstandardized interpretation at provider discretion.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor

761 Previous Clinical Trials

5,565,330 Total Patients Enrolled

2 Trials studying Communication

7,812 Patients Enrolled for Communication

Patient-Centered Outcomes Research InstituteOTHER

549 Previous Clinical Trials

29,982,148 Total Patients Enrolled

9 Trials studying Communication

13,700 Patients Enrolled for Communication

Pediatric Research in Inpatient SettingsUNKNOWN

Media Library

PFC I-PASS Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05591066 — N/A

Communication Research Study Groups: PFC I-PASS Intervention, PFC I-PASS+ Intervention, Usual care

Communication Clinical Trial 2023: PFC I-PASS Intervention Highlights & Side Effects. Trial Name: NCT05591066 — N/A

PFC I-PASS Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05591066 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many healthcare institutions are providing this clinical trial?

"This medical investigation is currently enrolling patients at 8 separate sites, with noteworthy locations being UPMC Children's Hospital of Pittsburgh in Pittsburgh, Northwest Texas Healthcare System in Amarillo, and The Research Institute of Nationwide Children's Hospital in Columbus."

Answered by AI

Are there any open recruitment slots for this research endeavor?

"According to information hosted on clinicaltrials.gov, this medical study is not presently recruiting patients. It was posted on November 1st 2022 and the last edit occurred October 19th 2022; however, 29 other studies are currently enrolling volunteers right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

Alisa Khan 2024. "The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05591066.